Filing Details
- Accession Number:
- 0001209191-19-044312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-02 17:23:50
- Reporting Period:
- 2019-08-01
- Accepted Time:
- 2019-08-02 17:23:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597313 | Viewray Inc. | VRAY | Electromedical & Electrotherapeutic Apparatus (3845) | 421777485 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1637089 | F. James Dempsey | C/O Viewray, Inc. 2 Thermo Fisher Way Oakwood Village OH 44146 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-01 | 5,146 | $0.68 | 226,119 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-01 | 5,146 | $8.98 | 220,973 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-01 | 16,469 | $0.68 | 237,442 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-01 | 16,469 | $8.97 | 220,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-08-01 | 5,146 | $0.00 | 61,752 | $0.68 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-08-01 | 16,469 | $0.00 | 197,635 | $0.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,457 | 2020-06-29 | No | 4 | M | Direct | |
| 164,697 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.73 to $9.19 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.70 to $9.21 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes 38,371 shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested.
- The shares subject to the option vested in 36 monthly installments beginning June 17, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 36 month anniversary of the Vesting Commencement Date.
- The shares subject to the option vested in 48 monthly installments beginning July 14, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
